IceCure Medical Ltd

NasdaqCM:ICCM Stock Report

Market Cap: US$67.4m

IceCure Medical Management

Management criteria checks 4/4

IceCure Medical's CEO is Eyal Shamir, appointed in Sep 2016, has a tenure of 8.33 years. total yearly compensation is $553.00K, comprised of 75.3% salary and 24.7% bonuses, including company stock and options. directly owns 0.95% of the company’s shares, worth $640.39K. The average tenure of the management team and the board of directors is 6.1 years and 5.3 years respectively.

Key information

Eyal Shamir

Chief executive officer

US$553.0k

Total compensation

CEO salary percentage75.3%
CEO tenure8.3yrs
CEO ownership1.0%
Management average tenure6.1yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Invest In Growth?

Jul 31
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Invest In Growth?

We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate

Nov 29
We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate

Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?

Aug 08
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?

IceCure gains 19% on seeking FDA nod for cancer treatment

Oct 19

IceCure files application for approval of ProSense in Canada for tumors

Jul 25

IceCure Medical: Advancing Cryotherapy For Cancer Treatment

Jan 25

CEO Compensation Analysis

How has Eyal Shamir's remuneration changed compared to IceCure Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$14m

Jun 30 2024n/an/a

-US$14m

Mar 31 2024n/an/a

-US$14m

Dec 31 2023US$553kUS$416k

-US$15m

Sep 30 2023n/an/a

-US$16m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$16m

Dec 31 2022US$658kUS$467k

-US$17m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$13m

Dec 31 2021US$489kUS$426k

-US$10m

Sep 30 2021n/an/a

-US$8m

Jun 30 2021n/an/a

-US$6m

Mar 31 2021n/an/a

-US$4m

Dec 31 2020US$420kUS$370k

-US$4m

Sep 30 2020n/an/a

-US$4m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019n/an/a

-US$5m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019n/an/a

-US$4m

Mar 31 2019n/an/a

-US$4m

Dec 31 2018US$350kUS$251k

-US$4m

Compensation vs Market: Eyal's total compensation ($USD553.00K) is about average for companies of similar size in the US market ($USD645.26K).

Compensation vs Earnings: Eyal's compensation has been consistent with company performance over the past year.

CEO

Eyal Shamir (63 yo)

8.3yrs

Tenure

US$552,996

Compensation

Mr. Eyal Shamir serves as Chief Executive Officer and Director at IceCure Medical Ltd. since September 2016 and December 2017 respectively. Mr. Shamir served as Chief Executive Officer of Tadbik Pack Ltd.,...

Leadership Team

NamePositionTenureCompensationOwnership
Eyal Shamir
CEO & Director8.3yrsUS$553.00k0.95%
$ 640.4k
Ronen Tsimerman
CFO & COO7.7yrsUS$405.26k0.56%
$ 378.3k
Tlalit Tel-Tzure
Vice President of Business Development & Global Marketing6.1yrsUS$320.70k0.29%
$ 192.5k
Merav Dotan
Vice President of Human Resources3.2yrsUS$282.17k0.11%
$ 71.5k
Galit Malik
Vice President of Operations & Service2.1yrsno data0.10%
$ 69.3k

6.1yrs

Average Tenure

55yo

Average Age

Experienced Management: ICCM's management team is seasoned and experienced (6.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Eyal Shamir
CEO & Director7.1yrsUS$553.00k0.95%
$ 640.4k
Sharon Levita
Independent External Director5.3yrsUS$205.58kno data
Oded Tamir
Independent External Director11.3yrsno data0.018%
$ 12.3k
Ron Mayron
Chairman of the Board7.1yrsUS$62.23k0.41%
$ 273.8k
Chun Hung Chan
Independent Director2.1yrsno datano data
Haixiang Li
Directorless than a yearno datano data
Yang Huang
Director4.8yrsno data0.13%
$ 90.2k

5.3yrs

Average Tenure

61yo

Average Age

Experienced Board: ICCM's board of directors are considered experienced (5.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 06:58
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IceCure Medical Ltd is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian Kemp DolliverBrookline Capital Markets
Yi ChenH.C. Wainwright & Co.
Anthony VendettiMaxim Group